article thumbnail

How the food allergy sector is benefitting from health tech’s recent boom

pharmaphorum

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. per person being spent on food allergy research. Luckily for those with food allergies, the food allergy sector has benefitted from this influx of funding.

Food 100
article thumbnail

Getting an Rx does not address health problems

World of DTC Marketing

Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise. While the population is more worried about COVID, they are killing themselves by overeating processed food and not getting any exercise.

Insurance 200
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Life Expectancy in Minorities - How Can Pharma React?

PharmExec

The segment also touches on structural racism factors like food deserts, “essential workers”, and holding doctors accountable. Our panelists talk about preventative health messaging and dynamics of health of a specific group of people to help improve the lifespan of all people, especially the underserved minority populations.

Doctors 52
article thumbnail

How Pharma Companies Can Benefit from eatNgage

eatNgage

How Pharma Companies Can Benefit from eatNgage. Research has shown that doctors who are treated to a meal by pharmaceutical reps, are more likely to prescribe the promoted drug. This is a convenient, yet personal way to meet with doctors and present information about new medications. Virtual Events. Virtual Sales. For Guests.

Pharma 52
article thumbnail

Pandemic Innovators: Pharma Marketing Strategies that Reinvent the In-Person Conversation

Pharmaceutical Representative Training

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.

article thumbnail

Inspiring Action: Pharma Advertisers as a Force to Address Climate-Related Health Inequities 

Eversana Intouch

Climate change and health inequities demand immediate attention, and pharma advertisers are uniquely positioned to drive change. Most of us who work in pharma advertising do so because we believe we can make a difference. This highlights the potential financial benefits of taking a stand on climate change and health equity.

Pharma 52
article thumbnail

Is it too late for Biogen?

World of DTC Marketing

Biogen will partner with Roche on the development, and potential sale of a promising cancer drug the Swiss pharma is advancing for several types of lymphoma, announcing Tuesday it’s exercised an option to share rights to the treatment. Food and Drug Administration on Biogen Inc.’s Top researchers who advised the U.S.